HealthNewsReview.org |
Harvard's Jerry Avorn warns against FDA loosening off-label marketing restrictions
HealthNewsReview.org He warns against easing the restrictions on drug companies marketing their drugs for uses for which they have not been approved – so-called off-label use. To help make his case, he points to the marketing of dietary supplements as an example of the ... |
June 30, 2015 at 11:40AM | marketing - Google News
Harvard's Jerry Avorn warns against FDA loosening off-label marketing restrictions - HealthNewsReview.org
marketing - Google News
Nenhum comentário:
Postar um comentário